Joseph Calarco

Joseph Calarco has a diverse and extensive work experience in the field of compliance and ethics in the pharmaceutical industry. Joseph has held various senior-level positions, including Senior Director of Compliance at SpringWorks Therapeutics, Senior Director of US Compliance at Idorsia Pharmaceuticals Ltd, and Vice President of Compliance at Nabriva Therapeutics plc.

Prior to these roles, Calarco served as the Chief Compliance Officer at Neos Therapeutics, Inc., where they were responsible for framing the strategic direction of the company's ethics and compliance program. Joseph also worked as the Director of Compliance & Ethics, U.S. Operations at Bristol-Myers Squibb, providing compliance expertise to business unit leaders and advising on regulatory enforcement trends.

Calarco's experience also includes director-level roles at Shire Pharmaceuticals, where they led compliance monitoring and investigations programs. Additionally, they have worked as a Senior Manager / Account Manager / Pharmaceutical Compliance Consultant at Compliance Implementation Services (CIS), where they conducted compliance and business risk assessments for pharmaceutical and biotech clients.

Earlier in their career, Calarco held roles in data management and study coordination at Merck, Aventis Behring, and the University of Pennsylvania.

Overall, Calarco's work experience demonstrates their expertise in compliance, ethics, and risk management in the pharmaceutical industry.

Joseph Calarco completed their education with a Bachelor of Science degree in Psychology from Drexel University in 1994. Joseph further pursued a Master's degree in Clinical Social Work from Bryn Mawr College, which they obtained between 2000 and 2002. In addition to their academic qualifications, Joseph Calarco obtained various certifications in fields such as investigative interviewing, workplace investigations, healthcare compliance, leadership effectiveness training, and six sigma green belt.